1. Durrieu G, LLau ME, Rascol O, Senard JM, Rascol A, Montastruc JL. Parkinson’s disease and weight loss: a study with anthropometric and nutritional assessment.
Clin Auton Res. 1992;2:153-157.
2. Kashihara K. Weight loss in Parkinson’s disease.
J Neurol. 2006;253 Suppl 7:VII38-VII41.
3. McDonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson’s disease.
Biol Psychiatry. 2003;54:363-375.
4. Uc EY, Struck LK, Rodnitzky RL, Zimmerman B, Dobson J, Evans WJ. Predictors of weight loss in Parkinson’s disease.
Mov Disord. 2006;21:930-936.
5. Bachmann CG, Trenkwalder C. Body weight in patients with Parkinson’s disease.
Mov Disord. 2006;21:1824-1830.
6. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.
Arch Neurol. 2003;60:387-392.
8. Hughes TF, Borenstein AR, Schofield E, Wu Y, Larson EB. Association between late-life body mass index and dementia: the Kame Project.
Neurology. 2009;72:1741-1746.
9. Cho JW, Baik JS, Lee MS. Mesencephalic midline change on transcranial sonography in early Parkinson’s disease patients with depression.
J Neurol Sci. 2011;310:50-52.
10. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study.
Neurology. 1992;42:1142-1146.
11. Kim HW, Yoon HR, Baik JS, Han JE, Han SW, Yu HJ. Validation of transcranial sonographic measurement of the brainstem raphe in Korean patients with Parkinson’s disease.
J Neurosonol Neuroimag. 2018;10:133-137.
12. Walter U, Hoeppner J, Prudente-Morrissey L, Horowski S, Herpertz SC, Benecke R. Parkinson’s disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Brain. 2007;130:1799-1807.
13. Walter U, Prudente-Morrissey L, Herpertz SC, Benecke R, Hoeppner J. Relationship of brainstem raphe echogenicity and clinical findings in depressive states.
Psychiatry Res. 2007;155:67-73.
14. Ryu JH, Lee MS, Baik JS. Sonographic abnormalities in idiopathic restless legs syndrome (RLS) and RLS in Parkinson’s disease.
Parkinsonism Relat Disord. 2011;17:201-203.
15. Leibowitz SF, Alexander JT. Hypothalamic serotonin in control of eating behavior, meal size, and body weight.
Biol Psychiatry. 1998;44:851-864.
16. Erritzoe D, Frokjaer VG, Haahr MT, Kalbitzer J, Svarer C, Holst KK, et al. Cerebral serotonin transporter binding is inversely related to body mass index.
Neuroimage. 2010;52:284-289.
17. Kim HJ, Oh ES, Lee JH, Moon JS, Oh JE, Shin JW, et al. Relationship between changes of body mass index (BMI) and cognitive decline in Parkinson’s disease (PD).
Arch Gerontol Geriatr. 2012;55:70-72.
18. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The campaign study.
Brain. 2004;127:550-560.
19. Hayashi R, Hanyu N, Tamaru F. Cognitive impairment in Parkinson’s disease: a 6year follow-up study.
Parkinsonism Relat Disord. 1998;4:81-85.
20. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, Middelkoop HA, et al. Cognitive impairment in Parkinson’s disease.
J Neurol Neurosurg Psychiatry. 2007;78:1182-1187.
21. Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L. Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project.
J Am Geriatr Soc. 2008;56:111-116.
22. Lorefält B, Ganowiak W, Pålhagen S, Toss G, Unosson M, Granérus AK. Factors of importance for weight loss in elderly patients with Parkinson’s disease.
Acta Neurol Scand. 2004;110:180-187.